Alere/HIP team up on remote CHF (congestive heart failure) monitoring:
This article was originally published in Clinica
Executive Summary
New York health plan HIP has become the first in the eastern US to introduce a remote monitoring system for congestive heart failure (CHF) patients. The system uses Alere Medical technology in a programme that enables doctors to intervene at critical stages by viewing real time information on patient symptoms. CHF affects some 5m people in the US, with new cases being diagnosed at the rate of 400,000 per year. Hospitalisation costs exceed $6bn. A quarter of a million patients die from the condition annually. HIP serves some 800,000 members.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.